The combined analysis of germline and somatic genome alterations in cancer, together with haplotype-resolved sequencing, may also reveal links between the impact of germline mutations such as HbS that create a cancer-promoting tissue environment and mutations in genes such as SMARCB1 that arise in this environment. The gene discussed is SMARCB1; the disease is cancer.